Borosil Limited Promoters Declare NIL Equity Share Encumbrance for FY26 Under SEBI Takeover Regulations

Borosil Limited's promoter Pradeep Kumar Kheruka has submitted a formal declaration to stock exchanges and the company's Audit Committee, confirming that the promoters and persons acting in concert (PAC) have not created any encumbrance on their equity shareholding in Borosil Limited during the financial year ended March 31, 2026. The declaration was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and was filed on April 2, 2026.

Declaration Details

The declaration, signed by Pradeep Kumar Kheruka in his capacity as Promoter of Borosil Limited, confirms that neither directly nor indirectly has any encumbrance been made on the equity shares held by the promoter group during the financial year ended March 31, 2026. It further states that as on March 31, 2026, NIL number of equity shares of Borosil Limited are encumbered by the promoters and PAC.

The filing was submitted to the following authorities:

BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001

National Stock Exchange of India Ltd, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051

Audit Committee of Borosil Limited, 1101, Crescenzo, G-Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400051

Persons Acting in Concert (PAC)

The declaration covers Pradeep Kumar Kheruka along with the following persons acting in concert, as listed in the enclosure submitted with the filing:

Sr. No.: Name of Shareholder 1 Kiran Kheruka 2 Rekha Kheruka 3 Pradeep Kumar Kheruka 4 Shreevar Kheruka 5 Gujarat Fusion Glass LLP 6 Spartan Trade Holdings LLP 7 Borosil Holdings LLP 8 Associated Fabricators LLP 9 Sonargaon Properties LLP 10 Croton Trading Private Limited 11 Alaknanda Ruia

Regulatory Context

The declaration is a mandatory annual compliance requirement under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters and PAC to confirm to the stock exchanges and the company's audit committee whether any encumbrance has been created on their shareholding during the preceding financial year. The confirmation of NIL encumbrance indicates that the promoter group's equity holdings in Borosil Limited remain free of any pledge or other encumbrance as of the close of the financial year ended March 31, 2026.

Borosil Limited has announced the allotment of 5,500 equity shares under its Employee Stock Option Scheme 2020, following the exercise of vested stock options by employees. The ESOP Share Allotment Committee approved this allotment through a circular resolution passed on April 28, 2026.

Share Allotment Details

The allotment comprises 5,500 equity shares with a face value of Re. 1 each, issued under the 'Borosil Limited – Employee Stock Option Scheme 2020' (NEW ESOS 2020). The key parameters of this allotment are presented below:

Parameter: Details Number of Shares Issued: 5,500 Face Value per Share: Re. 1 Exercise Price per Share: Rs. 138.29 Premium per Share: Rs. 137.29 Date of Issue: April 28, 2026

Impact on Share Capital

Following this allotment, the company's capital structure has been updated accordingly. The issued and paid-up equity share capital now stands at Rs. 11,95,87,629, divided into 11,95,87,629 equity shares of face value Re. 1 each.

Capital Structure: Post-Allotment Total Issued Shares: 11,95,87,629 Total Issued Share Capital: Rs. 11,95,87,629 Distinctive Numbers: 119582130 to 119587629

Regulatory Approvals

The company had previously secured necessary regulatory approvals for this ESOP scheme from both major stock exchanges:

National Stock Exchange of India Limited: In-principle approval received vide letter no. NSE/LIST/27500 dated July 08, 2021

BSE Limited: In-principle approval received vide letter no. DCS/FL/MJ/ESOP-IP/1353/2021-22 dated July 19, 2021

Share Characteristics

The newly allotted equity shares rank pari-passu with existing equity shares and are identical in all respects, including dividend payment rights and other shareholder benefits. The shares are issued in demat form and carry no lock-in restrictions. The company has filed the required disclosures under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.